Epstein JI - Search Results

1

The contemporary concept of significant versus insignificant prostate cancer.

Ploussard G, Epstein JI, Montironi R, Carroll PR, Wirth M, Grimm MO, Bjartell AS, Montorsi F, Freedland SJ, Erbersdobler A, van der Kwast TH. Ploussard G, et al. Among authors: epstein ji. Eur Urol. 2011 Aug;60(2):291-303. doi: 10.1016/j.eururo.2011.05.006. Epub 2011 May 17. Eur Urol. 2011. PMID: 21601982 Review.

2

Current and proposed biologic markers in prostate cancer.

Bostwick DG, Montironi R, Nogle R, Pretlow T, Miller G, Wheeler T, Epstein J, Sakr W. Bostwick DG, et al. J Cell Biochem Suppl. 1992;16H:65-7. doi: 10.1002/jcb.240501214. J Cell Biochem Suppl. 1992. PMID: 1289675 No abstract available.

3

Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia.

Partin AW, Carter HB, Chan DW, Epstein JI, Oesterling JE, Rock RC, Weber JP, Walsh PC. Partin AW, et al. Among authors: epstein ji. J Urol. 1990 Apr;143(4):747-52. doi: 10.1016/s0022-5347(17)40079-6. J Urol. 1990. PMID: 1690309 Free article.

4

The relationship of prostate specific antigen levels and residual tumor volume in stage A prostate cancer.

Carter HB, Partin AW, Epstein JI, Chan DW, Walsh PC. Carter HB, et al. Among authors: epstein ji. J Urol. 1990 Nov;144(5):1167-70; discussion 1170-1. doi: 10.1016/s0022-5347(17)39683-0. J Urol. 1990. PMID: 1700143

5

Management of stage D1 adenocarcinoma of the prostate: the Johns Hopkins experience 1974 to 1987.

Steinberg GD, Epstein JI, Piantadosi S, Walsh PC. Steinberg GD, et al. Among authors: epstein ji. J Urol. 1990 Dec;144(6):1425-32. doi: 10.1016/s0022-5347(17)39759-8. J Urol. 1990. PMID: 1700157 Free article.

6

Needle biopsy associated tumor tracking of adenocarcinoma of the prostate.

Bastacky SS, Walsh PC, Epstein JI. Bastacky SS, et al. Among authors: epstein ji. J Urol. 1991 May;145(5):1003-7. doi: 10.1016/s0022-5347(17)38513-0. J Urol. 1991. PMID: 2016779 Free article.

7

Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy.

Oesterling JE, Chan DW, Epstein JI, Kimball AW Jr, Bruzek DJ, Rock RC, Brendler CB, Walsh PC. Oesterling JE, et al. Among authors: epstein ji. J Urol. 1988 Apr;139(4):766-72. doi: 10.1016/s0022-5347(17)42630-9. J Urol. 1988. PMID: 2451037

8

Evaluation of transrectal ultrasound in the early detection of prostate cancer.

Carter HB, Hamper UM, Sheth S, Sanders RC, Epstein JI, Walsh PC. Carter HB, et al. Among authors: epstein ji. J Urol. 1989 Oct;142(4):1008-10. doi: 10.1016/s0022-5347(17)38971-1. J Urol. 1989. PMID: 2677409

9

A comparison of nuclear morphometry and Gleason grade as a predictor of prognosis in stage A2 prostate cancer: a critical analysis.

Partin AW, Walsh AC, Pitcock RV, Mohler JL, Epstein JI, Coffey DS. Partin AW, et al. Among authors: epstein ji. J Urol. 1989 Nov;142(5):1254-8. doi: 10.1016/s0022-5347(17)39049-3. J Urol. 1989. PMID: 2810502

10

Morphometric measurement of tumor volume and per cent of gland involvement as predictors of pathological stage in clinical stage B prostate cancer.

Partin AW, Epstein JI, Cho KR, Gittelsohn AM, Walsh PC. Partin AW, et al. Among authors: epstein ji. J Urol. 1989 Feb;141(2):341-5. doi: 10.1016/s0022-5347(17)40761-0. J Urol. 1989. PMID: 2913356

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,059 results

Search Page